RRC ID 39427
著者 Hosoya Y, Kitoh Y, Kobayashi E, Okabe R, Fujimura A, Kanazawa K.
タイトル Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro.
ジャーナル Cancer Lett
Abstract We tested the effect of tamoxifen alone and tamoxifen plus 5-fluorouracil (5-FU) on proliferation of two different types of gastric cancer cell lines using the WST-1 method. A high dose of tamoxifen suppressed the proliferation of KATOIII cells (poorly differentiated adenocarcinoma), but MKN28 cells (well-differentiated adenocarcinoma) were not affected. The combination of the two drugs resulted in a synergistic anti-proliferative activity on KATOIII cells. On the other hand, in the combination therapy, tamoxifen stimulated MKN28 cells to proliferate in a dose-dependent manner. TGF-beta1 secretion was not changed in KATOIII cells by tamoxifen plus 5-FU treatment but was down-regulated in MKN28 cells. Both cancer cell lines were judged as intracellular estrogen receptor (ER) negative. These data suggest that the anti-proliferative effects of tamoxifen plus 5-FU on KATOIII cells were not dependent on ER expression or TGF-beta1 secretion. On the other hand, their proliferative effects on MKN28 cells might be, in part, caused by the reduced secretion of TGF-beta1.
巻・号 140(1-2)
ページ 139-43
公開日 1999-6-1
DOI 10.1016/s0304-3835(99)00059-2
PII S0304-3835(99)00059-2
PMID 10403552
MeSH Adenocarcinoma / metabolism Adenocarcinoma / pathology Antineoplastic Combined Chemotherapy Protocols / pharmacology* Carcinoma, Signet Ring Cell / metabolism Carcinoma, Signet Ring Cell / pathology Cell Division / drug effects Dose-Response Relationship, Drug Fluorouracil / administration & dosage Fluorouracil / pharmacology Humans Receptors, Estrogen / metabolism Stomach Neoplasms / metabolism Stomach Neoplasms / pathology* Tamoxifen / administration & dosage Tamoxifen / pharmacology Time Factors Transforming Growth Factor beta / metabolism Tumor Cells, Cultured
IF 7.36
引用数 8
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞 MKN28(RCB1000)